Location History:
- Austin, TX (US) (2022)
- Durham, NC (US) (2022)
Company Filing History:
Years Active: 2022-2024
Title: David H Ashley: Innovator in Anatomical Replication and Tumor Response Prediction
Introduction
David H Ashley is a notable inventor based in Austin, TX (US). He has made significant contributions to the fields of anatomical structure replication and tumor response prediction. With a total of 3 patents, Ashley's work has the potential to impact medical practices and improve patient outcomes.
Latest Patents
One of Ashley's latest patents is a method and system for creating a replica of an anatomical structure. This innovative method involves accepting pictures of the anatomical structure of a subject and creating an object file that contains an initial model of the outside surface. The process includes cutting the initial model to a predetermined exterior shape, creating a positive model, and subsequently a negative model. The final negative model is used to create a negative mold, which is then utilized to cast a replica of the anatomical structure.
Another significant patent focuses on methods for predicting tumor response to immunotherapy. This involves testing tumor samples for mutational burden and expression profiles to predict an individual's responsiveness to immunotherapy comprising PVSRIPO. Those predicted to respond are treated with PVSRIPO, while those predicted not to respond are treated with alternative agents.
Career Highlights
Throughout his career, David H Ashley has worked with various institutions, including Duke University. His innovative approaches have garnered attention in the medical and research communities, showcasing his commitment to advancing healthcare technologies.
Collaborations
Ashley has collaborated with notable individuals such as Steven A Shubin, Sr. and Steven A Shubin, Jr. These collaborations have likely contributed to the development and refinement of his innovative ideas.
Conclusion
David H Ashley's contributions to the fields of anatomical replication and tumor response prediction highlight his role as a significant inventor. His patents reflect a dedication to improving medical practices and patient care through innovative solutions.